Vaccines will work against new G-strain, finds study

The virus which emerged from Wuhan was the D-strain. Most vaccines under development have been modelled on the original strain, which was common among sequences published early in the pandemic.

  • Updated On Oct 9, 2020 at 07:16 AM IST
Read by: 100 Industry Professionals
Reader Image Read by 100 Industry Professionals
In a major breakthrough for 321 Covid-19 vaccines being developed worldwide, a new study has found that they will work against the new G-strain mutation of the coronavirus, reports Chethan Kumar.

The new study by a team led by Indian-origin scientist Prof SS Vasan has been published in ‘npj-Vaccine’, brought out by Nature.

The virus which emerged from Wuhan was the D-strain. Most vaccines under development have been modelled on the original strain, which was common among sequences published early in the pandemic.

The virus, meanwhile, evolved to ‘G-strain’, the result of a mutation known as D614G. American scientist Dr Bette Korber flagged this to be of urgent concern on April 30, and since then, this strain has steadily replaced the D strain all over the world. It now accounts for about 85% of published SARS-CoV-2 genomes.
  • Published On Oct 9, 2020 at 07:16 AM IST
Be the first one to comment.
Comment Now

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles
Scan to download App